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Background: In patients with left ventricular hypertrophy (LVH), LV midwall fractional shortening (FS) is used as a
measure of LV systolic performance that is more physiologically appropriate than conventional FS. For evaluation of
LV volume and ejection fraction (EF), 2-dimensional (2D) echocardiography is more accurate than M-mode
echocardiography. The purpose of this study was to assess systolic performance by midwall EF using 2D speckle
tracking echocardiography (STE).
Methods: Sixty patients were enrolled in the study. Patients were divided into two groups with LVH (n = 30) and
without LVH (control group, n = 30). LV systolic function was compared between the two groups and the
relationships of left ventricular mass index (LVMI) with LV systolic parameters, including midwall EF, were
investigated.
Results: Midwall EF in the LVH group was significantly lower than that in the control group (42.8±4.4% vs. 48.1±4.1%,
p <0.0001). Midwall FS was also significantly lower in the LVH group (13.4±2.8% vs. 16.1±1.5%, p <0.0001), but EF did
not differ significantly between the two groups. There were significant correlations between midwall EF and LVMI
(r=0.731, p <0.0001) and between midwall FS and LVMI (r=0.693, p <0.0001), with midwall EF having the higher
correlation.
Conclusions: These results show that midwall EF can be determined using 2D STE. Midwall EF can be used to monitor
LV systolic dysfunction, which is not possible with conventional EF. Evaluation of midwall EF may allow assessment of
new parameters of LV systolic function in patients with LV geometric variability.
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echocardiographyIntroduction
Left ventricular (LV) systolic performance is often assessed
by ejection fraction (EF) and fractional shortening (FS). It
is said that despite depression of LV systolic function,
LVEF and LVFS are preserved in patients with left ven-
tricular hypertrophy (LVH) [1-6]. However, assessment of
LV systolic function at the endocardial surface is thought
to reflect a geometric change of the LV, rather than the
contractile function of the myocardium [4]. Midwall FS
has been used as a more physiologically appropriate meas-
urement of LV systolic performance in patients with LVH,
compared to conventional FS, and decreased midwall FS* Correspondence: hisao_yskw@yahoo.co.jp
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reproduction in any medium, provided the oris predictive of subsequent morbidity and mortality [1-9].
However, calculation of midwall FS is based on a limited
region of the LV, rather than the whole left ventricle.
Therefore, evaluation of midwall FS for assessment of LV
systolic performance may not be applicable in patients
with variable LV geometries. Two-dimensional (2D) echo-
cardiography is more accurate for evaluating LV volume
and EF compared with M-mode echocardiography, and
2D speckle tracking echocardiography (STE) allows meas-
urement of LV volume and EF without manual tracking
[10,11]. Therefore, the purpose of this study was to inves-
tigate the utility of midwall EF using 2D STE.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Population and study protocol
Sixty patients were enrolled in the study. Patients were
divided into two groups with LVH (n = 30) and without
LVH (control group, n = 30). LVH was defined as an LV
mass index (LVMI) >96 g/m2 for women and >114 g/m2
for men. The causative of patients with LVH was essen-
tial hypertension with the exception of chronic renal fail-
ure, idiopathic hypertrophic cardiomyopathy, amyloidosis.
Patients with myocardial infarction, atrial fibrillation,
valvular disorders, and any other structural heart disease
were excluded. Patients with poor echocardiographic
image quality in the apical 2-chamber and 4-chamber
views were also excluded. LV function was measured using
conventional echocardiography, tissue Doppler imaging
(TDI), and 2D-STE. LV systolic function was assessed by
EF, midwall FS, midwall EF, and longitudinal strain. Sys-
tolic function was compared between the two groups and
the relationships of LVMI with LV systolic parameters, in-
cluding midwall EF, were investigated. Ethical review
board approval from our hospital was obtained.
Conventional echocardiography
Echocardiographic studies were performed using commer-
cial equipment (X3 transducer, Philips iE33 system) with
the patient in the left lateral decubitus position. Images
were obtained using a 3.5-4.0 MHz transducer in the para-
sternal short-axis and apical 4-chamber views [12]. Inter-
ventricular septal thickness (IVST), posterior wall
thickness (PWT), left ventricular end-diastolic diameter
(LVDd), left ventricular end-systolic diameter (LVDs), left
atrial dimension (LAD), stroke volume (SV), and left ven-
tricular fractional shortening (LVFS) were determined
using standard echocardiographic 2D or M-mode mea-
surements. The IVST and PWT were measured in end
diastole. LV mass was calculated from 2D echocardio-
graphic measurements using the M-mode formula [13]
and was normalized to body surface area. Mitral inflow
velocity was traced and the peak early (E) and late (A) mi-
tral flow velocities, the ratio of the early to late peak vel-
ocities (E/A), and the deceleration time (DCT) of the E
velocity were derived from the velocity data. Midwall FS
methods used the fact that the volume of myocardium be-
tween the midwall and the endocardium must be pre-
served although thickness of it was changed during
cardiac cycle. Then, midwall FS was calculated using the
model of Shimizu et al. [1,5-7], as follows:
1.Midwall FS = (LVIDd +Hd/2) − (LVIDs +Hs/2)/(LVIDd
+Hd/2).
2. Volume of myocardium between the
midwall and the endocardium = (LVIDd +Hd/2)
3 −
LVIDd
3 = (LVIDs +Hs/2)
3 − LVIDs
3.
3.Hd = PWT + IVST.where LVID is the LV internal dimension, d is end dia-
stole, s is end systole, and H is the shell thickness. In dia-
stole, the inner and outer shells have, by definition,
equal thickness given by (PWT + IVST).
Tissue Doppler imaging
TDI was performed in all patients with images taken
based on the guidelines of the American Society of
Echocardiography [14]. Using the 4-chamber view, a
5-mm sample volume was placed at the septal and lat-
eral border of the mitral annulus. Annular velocities
were displayed in septal and lateral pulsed-wave TDI
and the early systolic mitral annular velocity (S’), the
early diastolic mitral annular velocity (E’), and the late
diastolic annular velocity (A’) were determined from the
average of septal and lateral data from the TDI record-
ings. The mitral E/E’ ratio was also calculated.
Real-time 2D imaging
2D image analysis was performed on digitally stored images
(X3 transducer, Philips iE33 system). Real-time 2D data sets
were obtained from the apical 2-chamber and 4-chamber
images. Images were recorded to allow for reliable operation
of the software (Q-Lab, Version 7.0, Philips Healthcare).
LV systolic strain measurement
Myocardial longitudinal strain measurement was assessed
on 4-chamber image with speckle tracking analysis. The
traced endcardium is automatically divided into six seg-
ments; septal, anteroseptal, anterior, lateral, posterior, and
inferior. The average peak strain measured in the longitu-
dinal directions defined as the longitudinal strain.
Midwall EF measurement
The midwall EF measurements were obtained using semi-
automated speckle tracking (Q-Lab, Version 7.0, Philips
Healthcare). Image acquisition was performed with end-
expiratory breath holding to reduce the scattering of
values. One cardiac cycle was analyzed in each patient.
The position of the midwall was determined using the
landmark of the midpoint between the epicardial and
endocardial borders depending on the LV wall thickness.
Anatomic landmarks, including these midpoints and a
point on the apical endocardium, were manually initialized
at the end of diastole only. Following this initialization, the
software automatically positioned sixteen regions of inter-
ests (ROI) on the midwall LV cavity surface. In systole, the
initial ROI was not positioned at the midpoint of the wall
thickness because systolic thickening of the inner layer is
larger than that of the outer layer. Further manual adjust-
ments of the position of the ROI in the end-diastolic
frame were performed as necessary [10]. A representative
case is shown in Figure 1A and 1B. Then, we automatically
obtained the volume curve using a speckle tracking
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end diastolic and end systolic volumes. A volume curve
obtained with the speckle tracking algorithm in a repre-
sentative case is shown in Figure 1C. Midwall EF was then
calculated by the biplane method using the average value
in the apical 4-chamber and 2-chamber views.
EF measurement
These data were obtained using the same method as that
for midwall EF measurement, except for the positions of
ROIs, which were based on anatomic landmarks, includ-
ing septal and lateral points on the mitral annulus and a
point on the apical endocardium. The EF was then cal-
culated from apical 4-chamber and 2-chamber views, as
for the midwall EF in 2D STE.
Statistical analysis
Data are expressed as means ± SD. A Student t-test was
used to compare continuous variables and a χ2 test was
used for categorical variables. Simple linear regression ana-
lysis was used to evaluate relationships between variables of
interest, with p < 0.05 considered to indicate significance.
Results
Patient characteristics
Of the 69 patients who were initially recruited, 9 were
excluded because the echocardiographic image qualityFigure 1 Examples of midwall EF measurements. (A) 4-chamber view. (
the landmark of the midpoint between the epicardial and endocardial bor
method. EF = ejection fraction. EDV = end diastolic volume; ESV = end syswas unsuitable for quantitative 2D STE analysis. Thus, 60
patients were subsequently enrolled in the study. Patients
were divided into two groups with LVH (n = 30) and with-
out LVH (control group, n = 30). The characteristics of
the patients in these groups are shown in Table 1. There
were no significant differences in mean age, gender,
height, weight, body mass index, and systolic and diastolic
blood pressure between the two groups. Frequencies of
diabetes mellitus and hyperlipidemia did not differ signifi-
cantly between the groups, but the frequency of hyperten-
sion in the LVH group was significantly higher than that
in the control group.
Echo parameters in conventional echocardiography
Echo parameters in the LVH and control groups are
shown in Table 2. The IVST and PWT in the LVH
group were larger (11.9±3.2 mm vs. 9.8±1.1 mm,
p <0.0001; 12.7±2.1 mm vs. 9.9±1.2 mm, p <0.0001, re-
spectively) and the LVMI was higher (132.2±28.3 g/m2
vs. 86.9±10.8 g/m2, p <0.0001) compared to the respect-
ive values in the control group. LVDd, LVDs, LVFS,
E velocity, A velocity, and E/A did not differ between
the two groups.
Systolic echo and TDI parameters
Systolic echo and TDI parameters are shown in Table 3.
The midwall EF in the LVH group was significantly lowerB) 2-chamber view. The positioning of the midwall is determined by
ders. (C) Examples of midwall volume curve using speckle tracking
tolic volume.
Table 1 Patient characteristics in the LVH and control
groups
Item LVH (n=30) Control (n=30) P-value
Age (years) 66.0±15.7 62.9±14.5 0.4321
Male (%) 18 (60%) 17 (56%) 0.5893
Height (cm) 160.6±9.2 161.6±9.6 0.6551
Weight (kg) 58.9±11.6 59.2±11.3 0.9121







Hypertension 30 (100%) 5 (16%) <0.0001
Diabetes mellitus 5 (16%) 4 (13%) 0.5892
Hyperlipidemia 12 (40%) 8 (27%) 0.1257
Data are shown as a number (%) or mean ± S.D. LVH = left ventricular
hypertrophy; BMI = body mass index. There were no significant differences in
mean age, gender, height, weight, BMI, systolic and diastolic blood pressure
between the two groups. Frequencies of diabetes mellitus and hyperlipidemia did
not differ significantly between the two groups, but the frequency of hypertension
in the LVH group was significantly higher than that in the control group.
Table 3 Systolic echo parameters in the LVH and control
groups
Item LVH (n=30) Control (n=30) P-value
EF (%) 58.7±4.8 59.3±5.5 0.6496
Midwall EF (%) 42.8±4.4 48.1±4.1 <0.0001
Midwall FS (%) 13.4±2.8 16.1±1.5 <0.0001
Longitudinal strain (%) −12.7±2.8 −15.1±2.2 0.0006
S’ (cm/s) 7.6±1.1 9.0±1.6 0.0021
A’ (cm/s) 8.7±1.7 9.4±1.9 0.1749
E’ (cm/s) 6.7±2.1 8.7±2.4 0.0013
E/E’ 9.0±3.1 7.4±2.1 0.0148
Data are shown as a number (%) or mean ± S.D. TDI = tissue Doppler imaging;
EF = ejection fraction; midwall EF = midwall ejection fraction; midwall FS =
midwall fractional shortening; S’ = peak systolic annular velocity; E’ = early
diastolic mitral annular velocity; A’ = late diastolic mitral annulus velocity; E/E’ =
ratio of E to E’. Midwall EF in the LVH group was significantly lower than that in
the control group. Midwall FS and longitudinal strain were also significantly lower
in the LVH group, but EF did not differ significantly between the two groups. S’
and E’ in the LVH group were lower than in the control group. E/E’ was higher
significantly in the LVH group.
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p <0.0001). Midwall FS and longitudinal strain were also
both significantly lower in the LVH group (13.4±2.8% vs.
16.1±1.5%, p <0.0001; -12.7±2.8% vs. -15.1±2.2%, p =0.0006,
respectively), but EF did not differ significantly between the
two groups (58.7±4.8% vs. 59.3±5.5%, p =0.6496). S’ and E’ inTable 2 Echo parameters in conventional
echocardiography in the LVH and control groups
Item LVH (n=30) Control (n=30) P-value
HR (bpm) 67.7±9.4 67.9±10.5 0.9252
LAD (mm) 40.6±4.7 35.6±3.6 0.0023
IVST (mm) 11.9±3.2 9.8±1.1 <0.0001
PWT (mm) 12.7±2.1 9.9±1.2 <0.0001
LVDd (mm) 43.2±4.9 43.1±4.1 0.9453
LVDs (mm) 26.5±3.9 26.9±3.4 0.6836
SV (mL) 56.1±15.7 55.2±13.8 0.8983
LVFS (%) 38.8±4.9 37.9±3.5 0.3844
LVMI (g/m2) 132.2±28.3 86.9±10.8 <0.0001
DCT (ms) 272.9±60.1 249.8±71.8 0.1823
E velocity (m/s) 56.7±14.8 61.8±16.1 0.1995
A velocity (m/s) 76.6±25.9 71.4±19.6 0.3847
E/A 0.81±0.33 0.97±0.52 0.1784
Data are shown as a number (%) or mean ± S.D. HR = heart rate; LAD = left
atrial dimension; IVST = interventricular septal thickness; PWT = posterior wall
thickness; LVDd = left ventricular end-diastolic diameter; LVDs = left
ventricular end-systolic diameter; SV = stroke volume; LVFS = left ventricular
fractional shortening; LVMI = left ventricular mass index; DCT = deceleration
time of the E-wave; E velocity = peak early mitral flow velocity; A velocity =
peak late mitral flow velocity; E/A = ratio of mitral E and A. IVST and PWT in
the LVH group were longer and LVMI was higher compared to the respective
values in the control group. LVDd, LVDs, LVFS, E velocity, A velocity, E/A did
not differ between the two groups.the LVH group were both significantly lower than those in
the control group (7.6±1.1 cm/s vs. 9.0±1.6 cm/s, p =0.0021;
6.7±2.1 cm/s vs. 8.7±2.4cm/s, p =0.0013, respectively), and
E/E’ was higher significantly in the LVH group (9.0±3.1 cm/s
vs. 7.4±2.1 cm/s, p =0.0148).
Relationships between echo parameters and LVMI
Relationships between echo parameters and LVMI are
shown in Table 4 and Figure 2. LVMI was not correlated
with EF (r=0.136, p=0.3003) (Figure 2A), but was signifi-
cantly correlated with midwall FS (r=0.693, p<0.0001)
(Figure 2B) and midwall EF (r=0.731, p<0.0001) (Figure 2C).
LVMI was correlated with longitudinal strain (r=0.552,
p<0.0001). LVMI was also correlated with S’ (r=0.386,
p=0.0023), E’ (r=0.389, p=0.0021), and E/E’ (r=0.292,
p=0.0234). Midwall EF showed the highest correlation with
LVMI.Table 4 Relationships between LVMI and echo parameters
Factor Correlation coefficient (r) P-value
EF 0.136 0.3003
Midwall EF 0.731 <0.0001
Midwall FS 0.693 <0.0001





The abbreviations are the same as those in Table 3. LVMI = left ventricular
mass index; The number of samples is 60 in this study. EF did not correlate
with LVMI. There were significant correlations between LVMI and midwall EF,
between LVMI and midwall FS. There was also significant correlatioms
between LVMI and longitudinal strain. S’ and E’ also correlated with LVMI.
Midwall EF had the highest correlation with LVMI.
Figure 2 Relationships between LVMI and systolic parameters in the 60 subjects in the study. (A) Relationship between LVMI and EF.
(B) Relationship between LVMI and midwall FS. (C) Relationship between LVMI and midwall EF. The abbreviations are the same as those in
Table 3. LVMI = left ventricular mass index.
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The reproducibility of the EF and midwall EF measure-
ments was evaluated by calculating the intra- and inter-
observer variability in 30 of the 60 patients selected at
random. The intra- and interobserver variabilities were
4.1±3.3% and 4.8±3.2%, respectively, for EF, and 6.1±4.4%
and 6.4±4.2%, respectively, for midwall EF.
Discussion
The midwall EF in the LVH group was significantly lower
than that in the control group and midwall EF was corre-
lated with the degree of LVH. Our study showed the utility
of midwall EF for assessing systolic performance of the
hypertrophic left ventricle. Also, this method may be clin-
ically useful and is likely to have low observer variability.
As far as we are aware, there has only been one previous
study of midwall EF. Jung et al. found that the midwall EF
also discriminates the systolic function between patients
with LVH and normal subjects [4], but the method used
required manual tracing of echocardiographic images and
a complicated calculation of echocardiographic data,
which limits the clinical utility.
LVH is an independent predictor of adverse cardiovas-
cular events in hypertension [9,15]. Accurate assessment
of cardiac function in patients with LVH is important in
clinical practice. LV systolic function has been wildly
assessed as the ratio of observed LV endocardial FS or
EF to value predicted by the level of end-systolic stressin normal subjects [3]. The degree of shortening and the
level of opposing forces in myocardium in patients with
LVH is different from normal subjects [6]. The previous
study reported that LVEF and LVFS are preserved in
patients with LVH, despite depression of LV myocardial
systolic function [1,3-6]. In this study, the midwall EF in
the LVH group was significantly lower than that in the
control group and the correlation of LVMI with midwall
EF was higher than that with any other parameters, in-
cluding midwall FS. Thus, midwall EF can be used to
monitor LV systolic dysfunction, which is not possible
with conventional LVEF and LVFS.
Midwall FS has been used to detect depressed LV sys-
tolic function in patients with LVH [1,3-5]. A previous
study found significant differences in midwall measure-
ments of the fiber shortening and lengthening velocities
in normal and hypertrophic patients [16]. The midwall
FS measurement is preferred because systolic wall thick-
ening is non-uniform, with the inner wall thickening to
a substantially greater extent than the outer wall. This
may be because fibers in the subendocardial and
subepicardial myocardium are orientated longitudinally,
whereas those in the midwall region are orientated cir-
cumferentially [4,7]. Ishizu et al. also showed differences
in radial strain between the inner and outer halves of the
myocardium and differences in circumferential strain
among the three layers in the endocardial, midwall, and
epicardial myocardium by strain analysis using 2D STE
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physiologically appropriate measurement of LV systolic
performance in patients with LVH, compared to conven-
tional FS [1,2,4-9]. However, midwall FS measurements
are inherently flawed because of foreshortening errors
and reliance upon geometric models that may be in-
accurate in the diseased heart [18]. Also, echocardio-
graphic calculation of midwall FS is a geometry-based
index derived from linear measurement of the posterior
and septal walls, and consequently cannot distinguish
between septal and posterior wall function [2]. There-
fore, calculation of midwall FS is made from a limited
region of the LV. In contrast, midwall EF can estimate
foreshortening without use of a geometric model be-
cause midwall EF is calculated in planes. Thus, measure-
ment of midwall EF is a relatively new approach that can
mitigate the errors inherent in midwall FS.
The correlation of LVMI with midwall EF was higher
than with TDI parameters. It has been suggested that
TDI can be used to quantify regional ventricular func-
tion objectively and the mitral annular velocity may be a
more sensitive index of LV function [19]. However, TDI
is particularly affected by translational and tethering
effects, and angle-dependency. Therefore, there is some
limitation in interpretation of measurements by TDI. In
contrast, analysis of midwall EF is relatively free of the
influence of these adverse affects. Thus, in a clinical set-
ting, measurement of midwall EF is effective for quanti-
fying the impairment of LV function due to LVH. It is
reported that the longitudinal strain is a useful method
for assessing myocardium systolic dysfunction in patients
with LVH [20]. Nonetheless, the correlation of LVMI with
midwall EF was higher than with longitudinal strain in our
study. Midwall EF measurements may be superior to de-
tect myocardial systolic dysfunction in patients with LVH
than longitudinal strain.
Our study also showed the usefulness of 2D STE for
measurement of midwall EF. The STE technique relies
on tracking of natural acoustic markers in the myocar-
dium from frame to frame throughout the cardiac cycle
using a sum of absolute differences algorithm [10]. Thus,
the application of 2D STE method has been widely used
in the study of subclinical or overt LV dysfunction [21].
Evaluation of midwall EF by 2D STE does not require
difficult or lengthy acquisition and offline reconstruc-
tion, which are impractical in routine clinical use. The
2D STE method also allows automatic measurements of
LV volume to be performed without the need for manual
tracings. We positioned the initial ROI manually on the
midpoint of the wall thickness at the end of diastole
only. Then, we automatically obtained the volume curve
using a speckle tracking algorithm throughout the car-
diac cycle. In systole, the initial ROI was not positioned
at the midpoint of the wall thickness because the systolicthickening of the inner layer is larger than that of the
outer layer. Ishizu et al. also proved this phenomenon
using a speckle tracking method [17]. Thus, our method is
similar to the mathematical midwall mechanism reported
in previous studies [1,2,4-9] and may be clinically useful
and is likely to have low observer variability.
In this study, midwall EF correlated with the degree of
LVH. Patients with LVH have intrinsic dysfunction in
both systole and diastole. Our study showed that mid-
wall EF can detect LV systolic dysfunction, which cannot
be detected by conventional EF. This may be an import-
ant sign of LV dysfunction in patients with hypertension,
which may not always be due to diastolic dysfunction,
but can often be caused by systolic dysfunction, as
assessed by midwall EF [6]. Evaluation of midwall EF
may allow assessment of LV systolic performance in
patients with various LV geometries. Our method is rela-
tively easy to apply in conventional echocardiography,
with clinical settings similar to those for volume meas-
urement by the routine biplane method.
Our methods demonstrated that the midwall EF is
clinically useful for detecting the systolic function in
addition to midwall FS, TDI, and strain. Midwall EF can
detect LV systolic dysfunction, which cannot be detected
by conventional EF. The intrinsic systolic dysfunction
may affect predictive of subsequent morbidity and mor-
tality in patients with LVH. Midwall EF will have possi-
bilities to detect the beneficial change of intrinsic systolic
dysfunction by medical treatment in clinical settings.
Study limitation
The current study has several limitations. First, we did
not examine the influence of afterload, which may affect
the midwall analysis. Second, the subjects did not consti-
tute a consecutive series and were selected according to
image quality. Finally, midwall EF using 2D STE is not
theoretically the same as conventional midwall FS, which
is needed to measure both systole and diastole.
Conclusion
The study showed that midwall EF can be evaluated
using 2D STE. The midwall EF in the LVH group was
significantly lower than that in the control group and
midwall EF was correlated with the degree of LVH. This
measurement can be used to detect LV systolic dysfunc-
tion, which cannot be detected by conventional EF.
Thus, evaluation of midwall EF may allow assessment of
new parameters of LV systolic function in patients with
various LV geometries.
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